Time to First-Line Antiretroviral Treatment Failure and its Predictors for Seropositive Children Treated in Public Hospitals, North West Ethiopia 2021

Fassikaw Kebede, B. Kebede, Tsehay Kebede, Mastewal Giza
{"title":"Time to First-Line Antiretroviral Treatment Failure and its Predictors for Seropositive Children Treated in Public Hospitals, North West Ethiopia 2021","authors":"Fassikaw Kebede, B. Kebede, Tsehay Kebede, Mastewal Giza","doi":"10.35248/1948-5964.21.S21.001","DOIUrl":null,"url":null,"abstract":"The magnitudes of Anti-Retroviral Treatment (ART) failure for adult people living with HIV (PLWH) were exhaustively studied; however, time to treatment failure among seropositive children was overlooked, and this study aimed to assess time to first-Line Antiretroviral treatment Failure for seropositive children. Methods: Facility-based retrospective follow-up study was conducted since 1 January 2016-30 December 2020. EPI- DATA version 3.2 and STATA/14 software were used for data entry and analysis, respectively. Proportional hazard assumption was checked for each variable and no variable was found with Schoenfeld residual test <0.05. Categorical variables at bi-variables Cox regression were assessed for candidates transferred at P-value <0.25 for multivariable Cox regression to claiming predictors associated for TB incidence rate at 95% CI at P<0.005. Results: A total of 710 recorded of ART files were reviewed with 96 children (13.5%) (95% CI: 11.2, 16.3) had developed treatment failures. The overall incidence rate of treatment failure was found 4.098 (95% CI: 3.35 to 5.02) per 1000 Person Month. Children being orphaned (AHR: 4.3, 95% CI: 2.17, 7.7), WHO stage III and IV (AHR: 3.5, 95% CI: 1.8, 7.4), Poor ART adherence 3.27 (AHR:3.27, 95% CI:1.54, 4.8), ART follow-up duration ≥ 72 months (AHR: 2.28, 95% CI: 1.2, 5.2), Missed CPT 6.7 (AHR-6.7; 95% CI: 3.6, 8.4), AZT-3TC-NVP 6.5 (AHR=6.5; 95% CI: 3.2, 18.2), AZT-3TC-EFV 2.9 (AHR=2.89, 95% CI: 2.89, 10.1) were associated with treatment failures. Conclusion: Sixty-two percent of treatment failures were occurred after 72 months of ART follow up with a higher incidence of treatment failures, which is unacceptable as compared with slandered reference <10%. Being a seropositive child ≥ 70 month on ART, WHO stage III and IV, ART regiment (AZT-3TC-NVP and AZT-3TC-EFV), Poor ART adherence, missing CPT, and orphanages were associated with treatment failure.","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":"111 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1948-5964.21.S21.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The magnitudes of Anti-Retroviral Treatment (ART) failure for adult people living with HIV (PLWH) were exhaustively studied; however, time to treatment failure among seropositive children was overlooked, and this study aimed to assess time to first-Line Antiretroviral treatment Failure for seropositive children. Methods: Facility-based retrospective follow-up study was conducted since 1 January 2016-30 December 2020. EPI- DATA version 3.2 and STATA/14 software were used for data entry and analysis, respectively. Proportional hazard assumption was checked for each variable and no variable was found with Schoenfeld residual test <0.05. Categorical variables at bi-variables Cox regression were assessed for candidates transferred at P-value <0.25 for multivariable Cox regression to claiming predictors associated for TB incidence rate at 95% CI at P<0.005. Results: A total of 710 recorded of ART files were reviewed with 96 children (13.5%) (95% CI: 11.2, 16.3) had developed treatment failures. The overall incidence rate of treatment failure was found 4.098 (95% CI: 3.35 to 5.02) per 1000 Person Month. Children being orphaned (AHR: 4.3, 95% CI: 2.17, 7.7), WHO stage III and IV (AHR: 3.5, 95% CI: 1.8, 7.4), Poor ART adherence 3.27 (AHR:3.27, 95% CI:1.54, 4.8), ART follow-up duration ≥ 72 months (AHR: 2.28, 95% CI: 1.2, 5.2), Missed CPT 6.7 (AHR-6.7; 95% CI: 3.6, 8.4), AZT-3TC-NVP 6.5 (AHR=6.5; 95% CI: 3.2, 18.2), AZT-3TC-EFV 2.9 (AHR=2.89, 95% CI: 2.89, 10.1) were associated with treatment failures. Conclusion: Sixty-two percent of treatment failures were occurred after 72 months of ART follow up with a higher incidence of treatment failures, which is unacceptable as compared with slandered reference <10%. Being a seropositive child ≥ 70 month on ART, WHO stage III and IV, ART regiment (AZT-3TC-NVP and AZT-3TC-EFV), Poor ART adherence, missing CPT, and orphanages were associated with treatment failure.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚西北部公立医院治疗血清阳性儿童一线抗逆转录病毒治疗失败的时间及其预测因素
对成年艾滋病毒感染者(PLWH)抗逆转录病毒治疗(ART)失败的程度进行了详尽的研究;然而,血清阳性儿童治疗失败的时间被忽视了,本研究旨在评估血清阳性儿童一线抗逆转录病毒治疗失败的时间。方法:2016年1月1日至2020年12月30日,在医院进行回顾性随访研究。数据录入采用EPI- DATA 3.2版本,数据分析采用STATA/14软件。对各变量进行比例风险假设检验,经Schoenfeld残差检验均未发现变量<0.05。对双变量Cox回归的分类变量进行评估,在多变量Cox回归的P值<0.25时转移到宣称与结核病发病率相关的预测因子,95% CI为P<0.005。结果:共回顾了710份ART档案,96名儿童(13.5%)(95% CI: 11.2, 16.3)出现治疗失败。治疗失败的总发生率为每1000人月4.098 (95% CI: 3.35 ~ 5.02)。孤儿(AHR: 4.3, 95% CI: 2.17, 7.7), WHO III期和IV期儿童(AHR: 3.5, 95% CI: 1.8, 7.4),抗逆转录病毒治疗依从性差3.27 (AHR:3.27, 95% CI:1.54, 4.8),抗逆转录病毒治疗随访时间≥72个月(AHR: 2.28, 95% CI: 1.2, 5.2),未完成CPT 6.7 (AHR-6.7;95% ci: 3.6, 8.4), azt-3tc-nvp 6.5 (ahr =6.5;95% CI: 3.2, 18.2), AZT-3TC-EFV为2.9 (AHR=2.89, 95% CI: 2.89, 10.1)与治疗失败相关。结论:62%的治疗失败发生在ART随访72个月后,治疗失败的发生率更高,与诽谤参考<10%相比,这是不可接受的。接受ART治疗≥70个月、WHO III期和IV期、ART治疗组(AZT-3TC-NVP和AZT-3TC-EFV)、ART依从性差、CPT缺失和孤儿院与治疗失败相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
siRNA-Inhibition of TIGAR Hypersensitizes Human Papillomavirus-Transformed Cells to Apoptosis Induced by Chemotherapy Drugs that Cause Oxidative Stress Coroless, effective ingredient isolated from traditional Chinese medicine for the prevention and treatment of Covid-19 An Exploratory Study on COVID-19 and the Rights of Children Based on Keyword Network Analysis Comorbidities of COVID-19 Patients with Low Cycle Threshold (Ct) Value of Nucleocapsid (N) Gene: An Application to Cluster-Based Logistic Model. A Questionnaire-Based Survey to Assess the Timing of Intubation in COVID-19 Pneumonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1